Showing results (11-20 of 238) with videos related to
Sort By:
Pageof 24
Expert Review of Anticancer Therapy|October 18, 2002
Current management and prognostic factors for adult ependymomaMichele Reni, Alba A BrandesCritical Reviews in Oncology/Hematology|June 26, 2007
Primary central nervous system lymphomaAndrés J M Ferreri, Michele ReniHematology/Oncology Clinics of North America|August 9, 2005
Prognostic factors in primary central nervous system lymphomasAndrés J M Ferreri, Michele ReniWorld Journal of Gastroenterology|June 13, 2012
Adjuvant treatment in biliary tract cancer: to treat or not to treat?Stefano Cereda, Carmen Belli, Michele ReniWorld Journal of Gastroenterology|September 13, 2012
Role of taxanes in pancreatic cancerCarmen Belli, Stefano Cereda, Michele ReniDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 30, 2023
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinomaGiulia Gasparini, Francesca Aleotti, Marco Palucci, et al.Cancer Treatment Reviews|September 5, 2017
Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategiesMarta Chiaravalli, Michele Reni, Eileen M O'ReillyCancer Chemotherapy and Pharmacology|November 7, 2020
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patientsMarina Macchini, Umberto Peretti, Giulia Orsi, et al.Clinical and Translational Radiation Oncology|May 23, 2024
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinomaPaolo Passoni, Michele Reni, Sara Broggi, et al.Frontiers in Oncology|September 27, 2021
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic AdenocarcinomaIlaria Trestini, Luisa Carbognin, Umberto Peretti, et al.Pageof 24